<DOC>
	<DOCNO>NCT00002706</DOCNO>
	<brief_summary>This randomized phase III trial study laparoscopic surgery see well work compare standard surgery treat patient endometrial cancer cancer uterus . Laparoscopic surgery less invasive type surgery cancer uterus may fewer side effect improve recovery . It know whether laparoscopic surgery effective standard surgery treat endometrial cancer .</brief_summary>
	<brief_title>Laparoscopic Surgery Standard Surgery Treating Patients With Endometrial Cancer Cancer Uterus</brief_title>
	<detailed_description>OBJECTIVES : I . Compare incidence surgical complication , peri-operative morbidity , mortality patient stage I IIa , grade I-III endometrial cancer uterine cancer undergo surgical staging laparoscopic assist vaginal hysterectomy v total abdominal hysterectomy . II . Compare length hospital stay surgery patient receive treatment . III . Compare quality life patient receive treatment . IV . Compare incidence location disease recurrence patient receive treatment . OUTLINE : This randomize , multicenter study . Patients randomize 1 2 treatment arm . ARM I : Patients undergo vaginal hysterectomy bilateral salpingo-oophorectomy ( BSO ) via laparoscopy . ARM II : Patients undergo total abdominal hysterectomy BSO via conventional laparotomy . Patients arm also undergo pelvic para-aortic lymph node sample . Quality life assess baseline , 1 , 3 , 6 week , 6 month . Patients follow 6 week , every 3 month 2 year , every 6 month 3 year .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Uterine Neoplasms</mesh_term>
	<criteria>Diagnosis stage I IIA , grade IIII endometrial adenocarcinoma uterine sarcoma Must consider candidate surgery No contraindication laparoscopy No clinical chest xray evidence metastasis beyond uterine corpus macroscopic involvement endocervix Performance status GOG 03 WBC least 3,000/mm^3 Platelet count least 100,000/mm^3 Bilirubin great 1.5 time normal SGOT great 3 time normal Creatinine great 2.0 mg/dL Prior malignancy allow current evidence disease Not pregnant No prior pelvic abdominal radiotherapy See Disease Characteristics No prior retroperitoneal surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>